In the Prime Therapeutic study cited above, only one in four patients were still on Wegovy or Ozempic two years later
According to the World Health Organization (WHO), approximately 890 million adults were living with obesity in 2022, while the International Diabetes Federation (IDF) estimated that 589 million adults aged 2079 years were living with diabetes globally in 2024, with the number expected to reach 853 million by 2050
Wegovy is approved by the FDA for several conditions: Weight loss and maintenance in adults and children 12 years and older who have obesity, and in adults who are overweight with at least one related health issue such as high blood pressure or high cholesterol
That content usually comes from clinic-style protocols or community protocol writeups, not from FDA-approved instructions for these research compounds
Phentermine side effects include elevated heart rate, increased blood pressure, insomnia, dry mouth, and the potential for dependency with longer use
While semaglutide is known to improve these metabolic parametersdata not captured in our studyour results suggest that in women with established infertility, these physiological benefits may not directly translate into improved clinical pregnancy or live birth rates, highlighting a distinction between spontaneous conception and fertility-related care